These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27807935)

  • 1. Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10.
    Hutchins J; Barajas RA; Hale D; Escaname E; Lynch J
    Pediatr Diabetes; 2017 Nov; 18(7):674-677. PubMed ID: 27807935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial.
    Berkowitz RI; Marcus MD; Anderson BJ; Delahanty L; Grover N; Kriska A; Laffel L; Syme A; Venditti E; Van Buren DJ; Wilfley DE; Yasuda P; Hirst K;
    Pediatr Diabetes; 2018 Mar; 19(2):191-198. PubMed ID: 28664624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and youth diabetes: distinguishing characteristics between islet cell antibody positive vs. negative patients over time.
    Rivera-Vega MY; Flint A; Winger DG; Libman I; Arslanian S
    Pediatr Diabetes; 2015 Aug; 16(5):375-81. PubMed ID: 25482141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal follow up of dysglycemia in overweight and obese pediatric patients.
    Love-Osborne KA; Sheeder JL; Nadeau KJ; Zeitler P
    Pediatr Diabetes; 2018 Mar; 19(2):199-204. PubMed ID: 28856775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes.
    Litonjua P; Piñero-Piloña A; Aviles-Santa L; Raskin P
    Endocr Pract; 2004; 10(2):101-6. PubMed ID: 15256325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Relapse of Hyperglycemia after Laparoscopic Roux-en-Y Gastric Bypass in T2DM Obese Patients: a 5-Year Follow-Up of 24 Cases.
    Xiaosong W; Chongyu S; Xuqi S; Peiwu Y; Yongliang Z
    Obes Surg; 2019 Apr; 29(4):1164-1168. PubMed ID: 30645722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents.
    Grinstein G; Muzumdar R; Aponte L; Vuguin P; Saenger P; DiMartino-Nardi J
    Horm Res; 2003; 60(3):121-6. PubMed ID: 12931039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents.
    Davies MJ; Leiter LA; Guerci B; Grunberger G; Ampudia-Blasco FJ; Yu C; Stager W; Niemoeller E; Souhami E; Rosenstock J
    Diabetes Obes Metab; 2017 Dec; 19(12):1798-1804. PubMed ID: 28432746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
    Guja C; Frías JP; Somogyi A; Jabbour S; Wang H; Hardy E; Rosenstock J
    Diabetes Obes Metab; 2018 Jul; 20(7):1602-1614. PubMed ID: 29473704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes.
    Bjornstad P; Hughan K; Kelsey MM; Shah AS; Lynch J; Nehus E; Mitsnefes M; Jenkins T; Xu P; Xie C; Inge T; Nadeau K
    Diabetes Care; 2020 Jan; 43(1):187-195. PubMed ID: 31685489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
    van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
    Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
    Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
    Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes mellitus in children and youth.
    Ramkumar S; Tandon N
    Indian J Pediatr; 2013 Mar; 80 Suppl 1():S87-94. PubMed ID: 23430571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy.
    Hollander P; Sugimoto D; Vlajnic A; Kilo C
    J Diabetes Complications; 2015; 29(8):1266-71. PubMed ID: 26281972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing spectrum of diabetes in Mexican American youth.
    Hale DE; Rupert G
    Rev Endocr Metab Disord; 2006 Sep; 7(3):163-70. PubMed ID: 17195113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
    Zhang B; Zhao J; Yang W;
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus in children and adolescents.
    Dileepan K; Feldt MM
    Pediatr Rev; 2013 Dec; 34(12):541-8. PubMed ID: 24295815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.
    Weinstock RS; Braffett BH; McGuigan P; Larkin ME; Grover NB; Walders-Abramson N; Laffel LM; Chan CL; Chang N; Schwartzman BE; Barajas RA; Celona-Jacobs N; Haymond MW;
    Diabetes Care; 2019 May; 42(5):903-909. PubMed ID: 30833375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obese adolescents with type 2 diabetes perform worse than controls on cognitive and behavioral assessments.
    Brady CC; Vannest JJ; Dolan LM; Kadis DS; Lee GR; Holland SK; Khoury JC; Shah AS
    Pediatr Diabetes; 2017 Jun; 18(4):297-303. PubMed ID: 27028236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.